iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://pubmed.ncbi.nlm.nih.gov/28765433/
Imaging in Parkinson's disease - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Jul;17(4):384.
doi: 10.7861/clinmedicine.17-4-384.

Imaging in Parkinson's disease

Richard J B Ellis  1 , Malcolm Steiger  1
Affiliations
Comment

Imaging in Parkinson's disease

Richard J B Ellis et al. Clin Med (Lond). 2017 Jul.
No abstract available

PubMed Disclaimer

Comment on

Similar articles

See all similar articles

References

    1. Damier P. Hirsch EC. Agid Y, et al. The substantia nigra of the human brain II. Patterns of loss of dopamine-containing neurons in Parkinson’s disease. Brain. 1999;122:1437–48. - PubMed
    1. Goa P. Zhou P-Y. Li G, et al. Visualisation of nigrosomes-1 in 3T MR susceptibility weighted imaging and its absence in diagnosing Parkinson’s disease. Eur Rev Med Pharmacol Sci. 2015;19:4603–9. - PubMed
    1. Langley J. Huddleston DE. Sedlacik J, et al. Parkinson’s disease-related increase of T2* weighted hypointensity in substantia nigra pars compacta. Mov Disord. 2017;32:441–9. - PubMed